Free Account Opening + AMC Free Demat
Loading...

Eris Lifesciences IPO vs IRB InvIT Fund IPO

Comparision between Eris Lifesciences IPO and IRB InvIT Fund IPO.

IPO Details

Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while IRB InvIT Fund IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the IRB InvIT Fund IPO is up to ₹5,921.10 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of IRB InvIT Fund IPO is ₹102.00 per share.

  Eris Lifesciences IPO IRB InvIT Fund IPO
Face Value ₹1 per share ₹102 per share
Issue Price (Lower) ₹600.00 per share ₹100.00 per share
Issue Price (Upper) ₹603.00 per share ₹102.00 per share
Issue Price (Final) ₹603.00 per share ₹102.00 per share
Discount (Retail)
Discount (Employee) ₹60.00 per share
Market Lot Size 24 shares 10000 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹4,300.00 Cr
OFS Issue Size 2,88,75,000 shares 3,47,61,770 shares
OFS Issue Size (Amount)
Issue Size Total 2,88,75,000 shares 58,05,00,000 shares
Issue Size Total (Amount) up to ₹1,741.16 Cr up to ₹5,921.10 Cr

IPO Timetable

Eris Lifesciences IPO opens on Jun 16, 2017, while IRB InvIT Fund IPO opens on May 03, 2017. The closing date of Eris Lifesciences IPO and IRB InvIT Fund IPO is Jun 20, 2017, and May 05, 2017, respectively.

  Eris Lifesciences IPO IRB InvIT Fund IPO
Anchor Bid Date
Issue Open Jun 16, 2017 May 03, 2017
Issue Close Jun 20, 2017 May 05, 2017
Basis Of Allotment (Tentative) Jun 23, 2017
Initiation of Refunds (Tentative) Jun 27, 2017
Credit of Share (Tentative) Jun 28, 2017
Listing date (Tentative) Jun 29, 2017
Anchor Lockin End date 1 Jul 23, 2017
Anchor Lockin End date 2 Sep 21, 2017

Financials

Eris Lifesciences IPO P/E ratio is , as compared to IRB InvIT Fund IPO P/E ratio of .

  Eris Lifesciences IPO IRB InvIT Fund IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in IRB InvIT Fund IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 13,69,07,797 shares in IRB InvIT Fund IPO.

  Eris Lifesciences IPO IRB InvIT Fund IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,17,500 shares 13,69,07,797 shares
NII 43,08,750 shares
RII 28,72,500 shares
Employee 1,50,000 shares
Others
Total 1,59,48,750 shares 25,09,90,397 shares

Bids Received (Subscription)

Eris Lifesciences IPO subscribed 3.29x in total, whereas IRB InvIT Fund IPO subscribed 8.57x.

  Eris Lifesciences IPO IRB InvIT Fund IPO
QIB (times) 4.68x 10.81x
NII (times) 0.45x
Big NII (times)
Small NII (times)
RII (times) 3.51x
Employee (times) 0.86x
Other (times) 5.89x
Total (times) 3.29x 8.57x

Comments

Add a public comment...